Natalia MorgunovaHead of Regulatory Affairs & PV Group Russia and Belarus at Novo Nordisk A/S, Russia
Natalia Morgunova is Head of RA and PV in Russia and Belarus for Novo Nordisk A/S, Russia and has been associated with NNAS over 20 years. She is pharmacist by background graduated from Moscow Medical Academy named after I.Sechenov and has around 25 years of experience in pharmaceutical industry in the Regulatory, Pharmacovigilance and Quality Assurance functions.
Natalia’s area of expertise includes in depth knowledge of the regulatory environment in Russia, regulatory activities pertaining to clinical trials and registration of new drugs including biological molecules and medical devices in Russia and Belarus as well as Russian GMP legislation.
She is responsible to provide regulatory guidance and strategic input to products and projects in various stages of clinical development and regulatory milestones and serves as an important link between global RA, Region and local RA in Russia and Belarus Affiliates to achieve successful regulatory submissions and approvals.